Up to one-quarter of individuals in criminal justice settings have an opioid use disorder. Medications for opioid use disorder, including buprenorphine, methadone, and naltrexone, are an effective treatment for individuals diagnosed with OUD. Previous literature has shown that such treatment is underutilized, but until now the association between specific geographical and institutional characteristics and the provision of MOUD has not been investigated in-depth. Learn about the role of geographical area, population density, facility type, and institutional characteristics in whether a facility provides MOUD based on a recent nationwide survey.
- Review current evidence in support of medications for opioid use disorder in correctional facilities
- Discuss significant associations between the provision of MOUD and demographic variables
- Explore the research findings' implications on expansion of access to MOUD in corrections